Lighthaven Capital to donate 25 per cent of performance fees to fund Covid-19 research

(Hedgeweek) Traditional long/short fund Lighthaven Capital has committed to help in the fight against coronavirus by donating 25 per cent of its performance fees to fund research into Covid-19. Here, Founder and CIO Eric Cheung explains how a forward-thinking outlook is key to the firm’s investment philosophy…

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply